This NIDDK Notice of Funding Opportunity seeks a single Coordination and Data Management Center (CDMC) to continue the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CPDPC). This grant supports ongoing longitudinal clinical studies on chronic pancreatitis (CP), including acute recurrent pancreatitis (ARP), and factors increasing pancreatic cancer risk in patients with CP, pancreatogenic diabetes (T3cDM), and newly diagnosed diabetes. Established in 2015, the CPDPC consortium extensively characterizes patients to understand CP pathophysiology and its sequelae like chronic pain, pancreatic insufficiency, T3cDM, and the diabetes/pancreatic cancer link. The chosen CDMC will facilitate free result sharing and collaborative projects among consortium members, leveraging combined expertise for impactful research. Applications close October 18, 2024.
Opportunity ID: 355755
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DK-25-020 |
| Funding Opportunity Title: | Single Source for Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC) (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 31, 2024 |
| Last Updated Date: | Jul 31, 2024 |
| Original Closing Date for Applications: | Oct 18, 2024 |
| Current Closing Date for Applications: | Oct 18, 2024 |
| Archive Date: | Nov 23, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $1,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See full Notice of Funding Opportunity for additional details on eligibility. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Notice of Funding Opportunity (NOFO) is a single source application for one Coordination and Data Management Center (CDMC) to continue the consortium to study Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CPDPC) to conduct and complete ongoing studies on chronic pancreatitis (CP) and factors that increase the risk of pancreatic cancer in patients (children and adults) with CP, pancreatogenic (type 3c) diabetes (T3cDM) and in patients with newly diagnosed diabetes. The CPDPC is composed of several Clinical Centers (CC) and one Coordination and Data Management Center (CDMC) The Consortium since its establishment in Fall 2015 has conducted longitudinal clinical studies with comprehensive epidemiological and biological characterization of patients with CP (including those with Acute Recurrent Pancreatitis, ARP) to gain insight into the pathophysiology of chronic pancreatitis and its sequela: chronic pain, pancreatic insufficiency, T3cDM and the diabetes/pancreatic cancer association. The consortium has also undertaken studies on the development of pancreatic cancer in newly diagnosed diabetic patients. Applications for the Consortium Clinical Centers are being solicited via RFA-DK-25-019 “Continuation of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Coordination and Data Coordinating Center (CPDPC-CCs) (U01) Clinical trial optional)”. The CDMC along with CCs will be expected to share results freely within Consortium and to continue the trans-Consortium collaborative projects that make use of the combined expertise and technological capabilities present in all of the Consortium members (see https://cpdpc.mdanderson.org/clinicalstudies.html). |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-25-020.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 355755 Full Announcement-RFA-DK-25-020 -> RFA-DK-25-020-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00287542 | Sep 18, 2024 | Oct 18, 2024 | View |
Package 1
Mandatory forms
355755 RR_SF424_5_0-5.0.pdf
355755 PHS398_CoverPageSupplement_5_0-5.0.pdf
355755 RR_OtherProjectInfo_1_4-1.4.pdf
355755 PerformanceSite_4_0-4.0.pdf
355755 RR_KeyPersonExpanded_4_0-4.0.pdf
355755 PHS398_ResearchPlan_5_0-5.0.pdf
355755 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
355755 RR_Budget_3_0-3.0.pdf
355755 RR_SubawardBudget30_3_0-3.0.pdf
355755 PHS398_ModularBudget_1_2-1.2.pdf
355755 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
